Leaderboards/IgG4-Related and Inflammatory Diseases

IgG4-Related and Inflammatory Diseases

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Shweta Mallikarjun Revannavar
Jawaharlal Nehru Medical College
2
Ryusuke Munemura
Kyushu University
3
Timil H. Patel
United States Food and Drug Administration
4
Ji Zongfei
Fudan University
5
Asami Nishikori
Okayama University
6
Akira Chinju
Kyushu University
7
Laura Whitworth
MRC Laboratory of Molecular Biology
8
Xiaohong Pu
Nanjing Drum Tower Hospital
9
Charlene Yu Lin Tang
Singapore General Hospital
10
Şafak Mirioğlu
Istanbul University

Rising Stars Papers

1
AA Amyloidosis: A Contemporary View
Current Rheumatology Reports|2024
43 cit.
2
Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group
Nephrology Dialysis Transplantation|2024
26 cit.
3
Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease
Journal of Clinical Pathology|2024
20 cit.
4
Prognostic factors and validation of the histologic chronicity score for C3 glomerulopathy: a registry analysis
Clinical Kidney Journal|2024
7 cit.
5
Serum and urine interferon-inducible protein 10, galectin-9, and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus
TURKISH JOURNAL OF MEDICAL SCIENCES|2024
6 cit.
6
Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use
Clinical Kidney Journal|2024
5 cit.
7
HER2 amplification subtype intrahepatic cholangiocarcinoma exhibits high mutation burden and T cell exhaustion microenvironment
Journal of Cancer Research and Clinical Oncology|2024
5 cit.
8
Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals during COVID-19
Clinical Cancer Research|2025
5 cit.
9
Distinct interleukin-6 production in IPL and TAFRO subtypes of idiopathic multicentric Castleman disease
Haematologica|2025
5 cit.
10
Immunoengineering for autoimmune-kidney disease
Nephrology Dialysis Transplantation|2024
3 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Zhanguo Li
Peking University
2
V K Vineeth
Nitte University
3
Fang Li
First People's Hospital of Chongqing
4
Jian Zhu
Zhejiang Medicine (China)
5
Marco Lanzillotta
Vita-Salute San Raffaele University
6
Brian A. Kudlow
University of Washington
7
Brady P. Culver
Exact Sciences (United States)
8
Zachary S. Wallace
Amgen (United States)
9
Nagaaki Katoh
Shinshu University
10
Ryuta Kamekura
Sapporo Medical University

Emerging Leaders Papers

1
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults
Annals of the Rheumatic Diseases|2023
87 cit.
2
Fibrotic phenotype of IgG4-related disease
The Lancet Rheumatology|2024
49 cit.
3
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
Seminars in Arthritis and Rheumatism|2022
48 cit.
4
Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortality
Lara D. Veeken|2022
38 cit.
5
The Association of Illness-related Uncertainty With Mental Health in Systemic Autoimmune Rheumatic Diseases
The Journal of Rheumatology|2022
20 cit.
6
Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases
Annals of the Rheumatic Diseases|2022
20 cit.
7
Safety of Janus Kinase Inhibitors: A Real-World Multicenter Retrospective Cohort Study
The Journal of Rheumatology|2023
19 cit.
8
Bibliometric analysis of publications on enthesitis in spondyloarthritis in 2012–2021 based on web of science core collection databases
Rheumatology International|2022
18 cit.
9
The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study
Annals of the Rheumatic Diseases|2022
17 cit.
10
The Positive Predictive Value of a Very High Serum IgG4 Concentration for the Diagnosis of IgG4-Related Disease
The Journal of Rheumatology|2022
16 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
John H. Stone
Twitter (United States)
2
Suresh T. Chari
The University of Texas MD Anderson Cancer Center
3
Kazuichi Okazaki
Kansai Medical University
4
Kendo Kiyosawa
Aizawa Hospital
5
Hirotaka Ohara
Nagoya City University
6
Yasuni Nakanuma
Fukui-ken Saiseikai Hospital
7
Yasuni Nakanuma
Fukui-ken Saiseikai Hospital
8
Günter Klöppel
Technical University of Munich
9
Louis P. Dehner
Jewish Hospital
10
Christopher D.�M. Fletcher
Brigham and Women's Hospital

Current Senior Leaders Papers

1
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
Lund University Publications (Lund University)|2002
2.8k cit.
2
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
New England Journal of Medicine|2001
2.7k cit.
3
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
Modern Rheumatology|2012
1.7k cit.
4
Extrapulmonary Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) A Clinicopathologic and Immunohistochemical Study of 84 Cases
The American Journal of Surgical Pathology|1995
1.6k cit.
5
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
Modern Rheumatology|2012
1.6k cit.
6
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
New England Journal of Medicine|2020
1.4k cit.
7
Trial of Tocilizumab in Giant-Cell Arteritis
New England Journal of Medicine|2017
1.4k cit.
8
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
Hepatology|1990
1.2k cit.
9
Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience
Clinical Gastroenterology and Hepatology|2006
975 cit.
10
Inflammatory Myofibroblastic Tumor
The American Journal of Surgical Pathology|2007
972 cit.

Reagents for IgG4-Related and Inflammatory Diseases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Cleaved Histone H3 (Thr22) (D7J2K) Rabbit Monoclonal Antibody

#12576$176,415
View Evidence →
Cell Signaling TechnologyEvidence 61

Phospho-PEA-15 (Ser104) Antibody

#2776$366,863
View Evidence →
Cell Signaling Technology

CCT2 Antibody

#3561$317
View Evidence →

🌟 All-Time

Most validated

Agilent/DakoEvidence 65

IgG

Cited in 10 papers
#A0423
View Evidence →
Cell Signaling TechnologyEvidence 65

PEA-15 Antibody

#2780$317
View Evidence →
Cell Signaling TechnologyEvidence 66

ICOS (D1K2T) Rabbit Monoclonal Antibody

#89601$157,366
View Evidence →